A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine

• Published in: Molecular pharmacology Vol. 29; no. 2; pp. 126 - 133
• Main Authors: JACOBSON, K. A, KIRK, K. L, PADGETT, W. L, DALY, J. W
• Format: Journal Article
• Language: English
• Published: Bethesda, MD American Society for Pharmacology and Experimental Therapeutics 01.02.1986
• Subjects: 1,3-dipropylxanthine; Adenosine - analogs & derivatives; Adenosine - antagonists & inhibitors; Adenosine - metabolism; adenosine A1; adenosine A2; Amino Acids - metabolism; Amino Acids - pharmacology; Animals; Binding, Competitive; Biological and medical sciences; brain; Cardiovascular system; Guinea Pigs; In Vitro Techniques; Medical sciences; Pharmaceutical Vehicles; Pharmacology. Drug treatments; Rats; Receptors, Cell Surface - drug effects; Receptors, Purinergic; Solubility; Structure-Activity Relationship; Vasodilator agents. Cerebral vasodilators; Xanthines - metabolism; Xanthines - pharmacology; Vertebrata; Adenosine; Cerebral cortex; Mammalia; Rat; Animal; Rodentia; Cyclic AMP; Antagonist; Biological receptor
• ISSN: 0026-895X; 1521-0111

1,3-Dipropyl-8-phenylxanthine, a synthetic analog of theophylline and a potent antagonist of adenosine at A1 and A2-adenosine receptors, has been attached covalently through a functionalized chain to amino acids and oligopeptides. The xanthine conjugates have been studied as competitive inhibitors of the specific binding of [3H]N6-cyclohexyladenosine to A1-receptors of rat cerebral cortical membranes and for inhibition of cyclic AMP accumulation elicited by 2-chloroadenosine in guinea pig brain slices through A2-receptors. A free amino group on the extended chain generally resulted in high potency at A1-receptors. The potency (in some cases extending into the subnanomolar range) and selectivity for A1-receptors (up to 200-fold) suggest that this approach can yield a versatile class of "functionalized congeners" of adenosine receptor antagonists in which distal modifications of the attached moiety ("carrier") can serve also to improve pharmacodynamic and pharmacokinetic parameters. The water solubility in many of the more potent analogs has been enhanced by two orders of magnitude over that of simple, uncharged 8-phenyl xanthine derivatives. Analogs in which the carrier contains D-tyrosine have potential for development of iodinated radioligands for adenosine receptors. The functionalized congener approach is potentially applicable to other drugs and for development of prodrugs.